• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Zimmer Biomet wins CE mark for Persona Knee

Zimmer Biomet wins CE mark for Persona Knee

November 18, 2024 By Sean Whooley

Zimmer Biomet Persona Revision Knee System (1)
The Persona Revision Knee system. [Image courtesy of Zimmer Biomet]
Zimmer Biomet (NYSE:ZBH) announced today that it received CE mark approval in Europe for its Persona Revision Knee system.

Warsaw, Indiana-based Zimmer Biomet said the addition to its Persona portfolio builds on its commitment to personalized solutions. Persona  Revision Knee provides advanced tools for revision knee arthroplasty.

The system offers a personalized fit and optimized function for patients undergoing revision knee surgery. A modular system, it allows for intraoperative flexibility. ZB said this enables surgeons to address a wide range of complex cases with precision and ease.

Persona Revision Knee features the orthopedic giant’s proprietary Trabecular Metal technology. This promotes long-term bone in-growth and improves implant fixation.

“After the successful introduction of Persona Revision Knee in the United States and other markets, the CE Mark certification and commercial launch extends its availability significantly so that more surgeons have access to an innovative solution that can enhance patient outcomes,” said Joe Urban, president, Knees at Zimmer Biomet.

Zimmer Biomet says Persona Revision Knee represents the leading product in the U.S. knee revision market valued at over $700 million. It has anatomic components and intuitive instrumentation, streamlining the revision surgery process. The company said it reduces complexity while improving precision.

With Persona Revision Knee, surgeons can make intraoperative adjustments to achieve optimal alignment and fit for each patient. This can lead to improved stability, mobility and implant longevity, according to ZB.

“We are excited to introduce the Persona Revision Knee to expand our industry-leading knee portfolio and to provide our customers and their patients with a system that is truly personalized, adaptable, and designed to restore natural knee motion,” said Wilfred van Zuilen, group president EMEA, Zimmer Biomet.

Filed Under: Featured, Implants, Orthopedic Implants, Orthopedics, Regulatory/Compliance Tagged With: Zimmer Biomet

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy